Jessica A Turner

This study predicts cognitive decline in Alzheimer's disease by integrating neuroimaging and clinical data, showing improved model performance with combined variables and introducing a new system for longitudinal analysis.

The paper introduces a framework using SHAP to identify FNC biomarkers distinguishing between schizophrenia patients and controls, and young vs. old adults with high accuracy.